The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | B | Blood and blood forming organs | |
| 2 | B06 | Other hematological agents | |
| 3 | B06A | Other hematological agents | |
| 4 | B06AX | Other hematological agents | |
| 5 | B06AX01 |
| Active Ingredient | Description | |
|---|---|---|
| Crizanlizumab |
Crizanlizumab-tmca is a humanized IgG2 kappa monoclonal antibody that binds to P-selectin and blocks interactions with its ligands including P-selectin glycoprotein ligand 1. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ADAKVEO Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
